A new study to be presented at the SLEEP 2026 annual meeting found that women with moderate-to-severe obstructive sleep apnea ...
1don MSN
A weight-loss drug that also controls sleep apnea and knee pain: Eli Lilly may have found one
Eli Lilly and its rivals, including Denmark's Novo Nordisk, are in a race to dominate the booming market for obesity and ...
A new study to be presented at the SLEEP 2026 annual meeting found that patients at high risk for obstructive sleep apnea who ...
Sleep often gets pushed to the bottom of the priority list. Busy schedules, family obligations, and endless distractions make ...
Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced ...
A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a ...
Researchers found a gut-related receptor tied to heart damage from sleep apnea, offering a potential new treatment target.
Drugmaker Eli Lilly presented trial results to medical professionals on Saturday showing its next-generation obesity drug retatrutide curbed sleep apnea severity in addition to boosting weight loss ...
New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...
But for millions of people, the hours don't matter, because what's happening during those hours is closer to suffocation than ...
A new sleep apnea pill reduced symptoms by 44 per cent in trials, offering hope for patients struggling with uncomfortable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results